Given its double-digit gains yesterday, now is a good time to discuss the rising star of INX Digital ( NEO:INXD ) ( OTC:INXDF ), a pioneering company that seeks to reshape capital markets through the integration of regulatory-compliant blockchain technology. INX Digital’s primary objective is to establish a regulated trading platform catering to digital...
Dr Reddy's Laboratories (NSE: DRREDDY)(NYSE: RDY) is a > MUN:10B pharma powerhouse based in India with a fast-expanding global footprint. This innovative juggernaut for pharma and biotech has witnessed a highly bullish price action uptrend YTD, with nearly 25% gains registered for its NSE ticker as of market close on Friday, situating share price some 5% above...
As we all know, its been a particularly volatile year for NASDAQ and tech equities across the board. At its lowest YTD (on 11.3), QQQ was down nearly 35%. A 7% intraday rally picked NASDAQ up from its bottom, but the trend is clear: with rising inflation, shrinking consumer savings, and broader downturns in the global macroeconomic environment, investors are...
The biotech sector is presenting exciting opportunities for investors despite the broader downturn in global equity markets. Many of the best biotech companies and ETFs have both strong drug candidate pipelines in the works as well as winning drugs and therapeutic products already on the market. The COVID-19 pandemic has proven and created massive opportunities...
$INNO.CN stock grew by +3.39% on Friday, stock opened at $0.590 and closed at $0.610, meanwhile price action is working above 20 EMA in daily chart that shows stock is bullish in nature and MACD is also showing strength in stock. RSI is close to par, indicating that current share price is fairly valued. The market cap of the company is 159.073M, and its average...
Its been a brutal year for Nasdaq, and $MITC is no exception. Its been tracking downwards since December after the Black Friday dip in major US indexes. While $MITC has underperformed $NDX, its smaller enterprise value makes this equity more vulnerable to background volatility, and the fact that the MITC and NDX price action's have followed the same course...
